Photo from ASCO/Twitter
Jul 21, 2023, 19:18
ASCO has been awarded $11M of PCORI research funding to study CDK4/6 inhibitors dosing in older adults w metastatic breast cancer
In a post by ASCO on Twitter, it says, “We’re pleased to announce ASCO has been awarded $11M of The Patient-Centered Outcomes Research Institute funding to study CDK4/6 inhibitors dosing in older adults w metastatic breast cancer. Led by our CMO Julie Gralow, the aim is to improve outcomes & fill a real-world evidence gap.”
For details: Click here
Source: ASCO/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 16, 2024, 12:06
Nov 16, 2024, 11:59
Nov 16, 2024, 11:50
Nov 16, 2024, 11:47
Nov 16, 2024, 11:40
Nov 16, 2024, 11:35
Nov 16, 2024, 11:32
Nov 16, 2024, 11:31